The effect of DASH-based weight loss diet on serum Lipopolysaccharide level and Metainflammation status among patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial

Abstract

adjustment to baseline values, changes in energy intake and physical activity. However, there was not any difference in ALT and AST/ALT between the groups.

Conclusion: Adherence to DASH diet for 8 weeks appears to be more effective in improving Meta-inflammation, LPS and liver steatosis than usual calorie-restricted diet.

Keywords: Dietary Approaches to Stop Hypertension (DASH), Non-alcoholic fatty liver disease (NAFLD), Meta-inflammation, and Lipopolysaccharides (LPS), Monocyte chemoattractant protein-1 (MCP-1), Toll-like receptor 4 (TLR4)